Abstract
With great interest we read the recent article from Iwai et al. entitled "Repeat-dose intravenous tranexamic acid further decreases blood loss in total knee arthroplasty" [1]. The authors report on the use of tranexamic acid to reduce the rate of peri-operative blood transfusions in patients undergoing total knee arthroplasty (TKA). We agree fully with the authors that the development of strategies to reduce blood loss and the rate of peri-operative transfusions is imperative in modern TKA surgery. However, we have some concerns related to the published work.
Original language | English |
---|---|
Pages (from-to) | 1417-1418 |
Number of pages | 2 |
Journal | The Journal of Arthroplasty |
Volume | 37 |
Issue number | 7 |
Early online date | 25 Apr 2013 |
DOIs | |
Publication status | Published - Jul 2013 |
Keywords
- Total Knee Arthroplasty
- Enoxaparin
- Tranexamic Acid
- Allogenic Transfusion
- Genicular Artery